Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
J&J: Strong sales growth in McNeil's Viactiv chewable calcium supplements was "substantially offset" by declines in adult analgesics, Imodium franchise during Q3, J&J reports in 1quarterly release and analysts call Oct. 15. Tylenol, Motrin marketer says Q3 adult analgesic sales compared unfavorably to year-ago period, "when retail inventories were built in anticipation of the fourth quarter flu season. Retailers are being more conservative this year and not stocking in similar fashion," according to J&J VP-Investor Relations Helen Short. Imodium also suffered in comparison to year-ago quarter, when Imodium Advanced caplets launched. McNeil worldwide sales rose a slight 1% to $448 mil. for the quarter, with U.S. sales gaining 3% to $387 mil. and international sales dropping 12% to $61 mil...